ASGCT News

FilterBy

The Near Future of Gene Therapy Regulation

In a meeting with ASGCT organizational partner Research America, Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research (CBER), discussed FDA guidance documents and elaborated on the agency’s interaction with their European counterparts in relation to gene and cell therapy.

The Near Future of Gene Therapy Regulation
July 02, 2018

In a meeting with ASGCT organizational partner Research America, Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research (CBER), discussed FDA guidance documents and elaborated on the agency’s interaction with their European counterparts in relation to gene and cell therapy.

ASGCT Offers Up To $245,000 in Career Development Grants
June 11, 2018

In support of trainees and members developing their careers, the American Society of Gene & Cell Therapy will distribute up to 14 grants worth a total of $245,000 in 2018. Applications are accepted through August 1.

2018 Annual Meeting By the Numbers
May 31, 2018

The American Society of Gene & Cell Therapy's 22nd Annual Meeting was the Society's largest in history. Check out some of the highlight stats from the May event.

ASGCT Releases White Paper Addressing the Value of Gene Therapy
May 11, 2018

The American Society of Gene & Cell Therapy has issued a white paper addressing the value of current and future gene therapies approved for clinical use in the United States.

Download the Annual Meeting Mobile App
May 08, 2018

Maximize your ASGCT Annual Meeting with the newly-updated mobile app!

2019
22nd Annual Meeting
April 29 – May 2 | Washington D.C.
Close